Penserra Capital Management LLC bought a new stake in Relx Plc (NYSE:RELX – Get Rating) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,485 shares of the technology company’s stock, valued at approximately $36,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. US Bancorp DE lifted its holdings in Relx by 216.4% in the 3rd quarter. US Bancorp DE now owns 427,253 shares of the technology company’s stock valued at $10,386,000 after purchasing an additional 292,228 shares in the last quarter. Fiera Capital Corp lifted its holdings in Relx by 8.9% in the 2nd quarter. Fiera Capital Corp now owns 32,900 shares of the technology company’s stock valued at $886,000 after purchasing an additional 2,700 shares in the last quarter. Zions Bancorporation N.A. lifted its holdings in Relx by 13.7% in the 2nd quarter. Zions Bancorporation N.A. now owns 17,114 shares of the technology company’s stock valued at $461,000 after purchasing an additional 2,056 shares in the last quarter. OLD Mission Capital LLC lifted its holdings in shares of Relx by 132.8% during the 2nd quarter. OLD Mission Capital LLC now owns 76,875 shares of the technology company’s stock worth $2,071,000 after acquiring an additional 43,860 shares during the period. Finally, Sit Investment Associates Inc. lifted its holdings in shares of Relx by 6.6% during the 2nd quarter. Sit Investment Associates Inc. now owns 94,805 shares of the technology company’s stock worth $2,554,000 after acquiring an additional 5,885 shares during the period. 3.41% of the stock is currently owned by hedge funds and other institutional investors.
Relx Trading Up 1.1 %
RELX opened at $30.57 on Tuesday. The firm has a 50 day moving average price of $29.04 and a 200 day moving average price of $27.47. Relx Plc has a 1 year low of $23.39 and a 1 year high of $32.24. The company has a debt-to-equity ratio of 1.56, a current ratio of 0.59 and a quick ratio of 0.53.
Relx Increases Dividend
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on RELX shares. Morgan Stanley cut their price objective on shares of Relx from GBX 3,020 ($36.44) to GBX 2,950 ($35.60) in a report on Friday, December 16th. JPMorgan Chase & Co. increased their price objective on shares of Relx from GBX 2,730 ($32.94) to GBX 2,810 ($33.91) in a report on Thursday, January 26th. Credit Suisse Group increased their price objective on shares of Relx from GBX 2,800 ($33.79) to GBX 2,860 ($34.51) in a report on Friday, February 17th. Barclays lowered shares of Relx from an “overweight” rating to an “equal weight” rating in a report on Tuesday, January 31st. Finally, StockNews.com started coverage on shares of Relx in a report on Wednesday, November 30th. They set a “hold” rating on the stock.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Get a free copy of the StockNews.com research report on Relx (RELX)
- Reserve Your Spot With These Hotels The Analysts Support
- Cruise Line Stocks Still Have Some Choppy Waters to Navigate
- Four Vegan Food Stocks Performing Beyond the Norm
- Ocean Interest Electrifies Fisker Stock
- Is Freshpet Ready For A Fresh Rally?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Get Rating).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
